Santen is engaged in the global research and development, manufacturing, and sales and marketing of pharmaceutical products in the field of eye care, supporting the eye health of people worldwide.
Based on our high level of expertise in the field of ophthalmology, we seek to provide value through our products and services to meet the unmet needs of patients and the ophthalmic medical community. Our portfolio spans more than 70 products, covering a wide range of eye diseases with products now available in more than 60 countries and territories.
- *1 Based on FY2024 data.
- *2 Source: Copyright © 2025 IQVIA. JPM 2024.4–2025.3. Santen analysis based on IQVIA data. Reprinted with permission.
- *3 Excluding retina segment. Source: Copyright © 2025 IQVIA. IQVIA MIDAS 2024.Q1–2024.Q4. Santen analysis based on IQVIA data. Reprinted with permission.
- *4 Excluding retina segment. Countries and regions included: South Korea, Vietnam, Thailand, Philippines, Indonesia, Malaysia, Singapore, Taiwan, and Hong Kong. Source: Copyright © 2025 IQVIA. IQVIA MIDAS 2024.Q1–2024.Q4. Santen analysis based on IQVIA data. Reprinted with permission.
- *5 Production at our factory. Single-dose containers are aggregated by counting 10 single-dose containers as 1 bottle. All other products are counted based on the actual number of bottles.
Partnering
Production
Official SNS
